Income Tax Expense (Benefit) of Poseida Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Poseida Therapeutics, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2019 to 30 Sep 2024.
  • Poseida Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2024 was $43,000, a 60% decline year-over-year.
  • Poseida Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $107,000, a 80% decline from 2022.
  • Poseida Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $544,000.
  • Poseida Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Poseida Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $43,000 -$64,000 -60% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q3 2023 $107,000 -$145,000 -58% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q3 2022 $252,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3

Poseida Therapeutics, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $107,000 -$437,000 -80% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2024 2023 FY
2022 $544,000 +$544,000 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 10 Mar 2022 2021 FY
2020 $0 $0 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
2019 $0 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.